Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Jurnal

Atherosclerosis

ISSN:
0021-9150
2
h-indeks
27
Iqtiboslar
126
Asarlar

Ishonch signallari

1 dan 3 signal mavjud

Mustaqil ijobiy signallar — yagona “predator/qonuniy” hukmi emas, balki yaqinlashuvchi tasvir.

  • DOAJ
    Maʼlumot yoʻq
    doaj.org
  • OAK roʻyxati
    Maʼlumot yoʻq
    OAK
  • Yaroqli ISSN
    Mavjud
    ISSN

Bu axborot yorligʻi, rasmiy qaror emas. Signal yoʻqligi jazo emas — masalan, mintaqaviy jurnal DOAJ'da boʻlmasligi mumkin.

Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
0510152003581020172018201920202021202220232024202520262017: Nashrlar 8, Iqtiboslar 02018: Nashrlar 6, Iqtiboslar 02019: Nashrlar 2, Iqtiboslar 12020: Nashrlar 20, Iqtiboslar 42021: Nashrlar 10, Iqtiboslar 82022: Nashrlar 8, Iqtiboslar 12023: Nashrlar 17, Iqtiboslar 22024: Nashrlar 9, Iqtiboslar 42025: Nashrlar 8, Iqtiboslar 32026: Nashrlar 1, Iqtiboslar 4

Iqtibos tarixi

03581020172018201920202021202220232024202520262017: Iqtiboslar 02018: Iqtiboslar 02019: Iqtiboslar 12020: Iqtiboslar 42021: Iqtiboslar 82022: Iqtiboslar 12023: Iqtiboslar 22024: Iqtiboslar 42025: Iqtiboslar 32026: Iqtiboslar 4

Nashr tarixi

0510152020172018201920202021202220232024202520262017: Nashrlar 82018: Nashrlar 62019: Nashrlar 22020: Nashrlar 202021: Nashrlar 102022: Nashrlar 82023: Nashrlar 172024: Nashrlar 92025: Nashrlar 82026: Nashrlar 1

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

01220172018201920202021202220232024202520262017: h-indeks 02018: h-indeks 02019: h-indeks 12020: h-indeks 12021: h-indeks 22022: h-indeks 22023: h-indeks 22024: h-indeks 22025: h-indeks 22026: h-indeks 2

Eng koʻp iqtibos qilingan asarlar

  1. Comparative Analysis Of The Inflammatory Biomarkers In Patients With Stable Coronary Artery Disease And Metabolic Syndrome20195 iqtibos
  2. Influence of diet with low glycemic index on triglycerides, glycated hemoglobin and LDL-C/HDL-C ratio in patients with coronary artery disease20203 iqtibos
  3. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)20182 iqtibos
  4. Combination lipid lowering therapy with rosuvastatin and ezetimibe in dyslipidemic patients with stable coronary artery disease and metabolic syndrome20182 iqtibos
  5. Efficacy of clopidogrel in patients with coronary artery disease after PCI considering with genetic polymorphisms20202 iqtibos
  6. Prognostic value of metabolic syndrome for the development of type 2 diabetes mellitus and cardiovascular disease20202 iqtibos
  7. Influence of combination therapy of rosuvastatin and telmisartan on vascular and metabolic profile in hypercholesterolemic patients with metabolic syndrome20171 iqtibos
  8. Influence of high doses of atorvastatin on myocardial stanning in acute myocardial infarction20171 iqtibos
  9. Efficiency and safety of rosuvastatin in patients with metabolic syndrome20171 iqtibos
  10. Burden of familial heterozygous hypercholesterolemia in Uzbekistan: Time is muscle20181 iqtibos
AkademIndex'da koʻrish →